Skip to content

Haemonetics HAE Earnings yield

Earnings yield at other companies

Abbott logo
AbbottABT
3.5%-2.4pp
TFX
TeleflexTFX
-19.1%-21.5pp
Boston Scientific logo
Boston ScientificBSX
3.8%+2.5pp
Medtronic logo
MedtronicMDT
4.6%+0.3pp
LivaNova logo
LivaNovaLIVN
-7.6%-8.4pp
ICU Medical logo
ICU MedicalICUI
-0.2%-0.1pp

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

Based on trailing twelve months.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's earnings yield?
Haemonetics (HAE) reported earnings yield of 4.7% in Q4 2025.
How has Haemonetics's earnings yield changed year-over-year?
Haemonetics's earnings yield increased by 41.0% year-over-year, from 3.3% to 4.7%.
What is the long-term trend for Haemonetics's earnings yield?
Over 4 years (2021 to 2025), Haemonetics's earnings yield has grown at a 39.2% compound annual growth rate (CAGR), from 1.4% to 5.3%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.